Tyvaso DPI

Tyvaso DPI · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

May 14, 2027

311 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (80)

Feb 3, 2042method-of-use (U-3749)US 11826327
Feb 3, 2042method-of-use (U-3749)US 11826327
Feb 3, 2042method-of-use (U-3749)US 11826327
Feb 3, 2042method-of-use (U-3749)US 11826327
Feb 3, 2042method-of-use (U-3749)US 11826327
Feb 3, 2042method-of-use (U-3749)US 11826327
Apr 1, 2035formulationUS 10421729
Apr 1, 2035formulationUS 10421729
Apr 1, 2035formulationUS 10421729
Apr 1, 2035formulationUS 10421729
Apr 1, 2035formulationUS 10421729
Jun 11, 2030formulationUS 107728833.9y
Jun 11, 2030formulationUS 107728833.9y
Jun 11, 2030formulationUS 107728833.9y
Jun 11, 2030formulationUS 107728833.9y
Jun 11, 2030formulationUS 107728833.9y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Mar 29, 2029formulationUS 79990072.7y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 117238872.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Dec 15, 2028compositionUS 95930662.4y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86531372.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
Sep 5, 2028method-of-use (U-1437)US 86586942.2y
May 5, 2028method-of-use (U-1849)US 93582401.8y
Mar 10, 2028formulationUS 93395071.7y
May 14, 2027method-of-use (U-1849)US 10376525311d
May 14, 2027method-of-use (U-1849)US 11357782311d
May 14, 2027method-of-use (U-1849)US 11357782311d
May 14, 2027method-of-use (U-1849)US 11357782311d
May 14, 2027method-of-use (U-1849)US 11357782311d
May 14, 2027method-of-use (U-1849)US 11357782311d

Tyvaso DPI

all catalysts(0)

News(0)

Patent cliff

patents (80)

comments(0)

Report a data issue

🐶 often sniffed alongside

Trials studying Tyvaso DPI